(Translated by https://www.hiragana.jp/)
Haloprogin – Wikipedija/Википедија Prijeđi na sadržaj

Haloprogin

Izvor: Wikipedija
Haloprogin
Klinički podaci
Robne marke Aloprogen, Haloprogin [USAN:INN:JAN], Haloprogina [INN-Spanish], Haloprogine [INN-French]
AHFS/Drugs.com Monografija
Identifikatori
CAS broj 777-11-7
ATC kod D01AE11
PubChem[1][2] 3561
DrugBank DB00793
ChemSpider[3] 3440
ChEMBL[4] CHEMBL1289 DaY
Hemijski podaci
Formula C9H4Cl3IO 
Mol. masa 361,391
SMILES eMolekuli & PubHem
Fizički podaci
Tačka topljenja 113.5 °C (236 °F)
Farmakoinformacioni podaci
Trudnoća ?
Pravni status

Haloprogin je organsko jedinjenje, koje sadrži 9 atoma ugljenika i ima molekulsku masu od 361,391 Da.[5][6]

Osobine

[uredi | uredi kod]
Osobina Vrednost
Broj akceptora vodonika 1
Broj donora vodonika 0
Broj rotacionih veza 3
Particioni koeficijent[7] (ALogP) 4,7
Rastvorljivost[8] (logS, log(mol/L)) -5,9
Polarna površina[9] (PSA, Å2) 9,2

Reference

[uredi | uredi kod]
  1. Li Q, Cheng T, Wang Y, Bryant SH (2010). „PubChem as a public resource for drug discovery.”. Drug Discov Today 15 (23-24): 1052-7. DOI:10.1016/j.drudis.2010.10.003. PMID 20970519.  edit
  2. Evan E. Bolton, Yanli Wang, Paul A. Thiessen, Stephen H. Bryant (2008). „Chapter 12 PubChem: Integrated Platform of Small Molecules and Biological Activities”. Annual Reports in Computational Chemistry 4: 217-241. DOI:10.1016/S1574-1400(08)00012-1. 
  3. Hettne KM, Williams AJ, van Mulligen EM, Kleinjans J, Tkachenko V, Kors JA. (2010). „Automatic vs. manual curation of a multi-source chemical dictionary: the impact on text mining”. J Cheminform 2 (1): 3. DOI:10.1186/1758-2946-2-3. PMID 20331846.  edit
  4. Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, McGlinchey S, Michalovich D, Al-Lazikani B, Overington JP. (2012). „ChEMBL: a large-scale bioactivity database for drug discovery”. Nucleic Acids Res 40 (Database issue): D1100-7. DOI:10.1093/nar/gkr777. PMID 21948594.  edit
  5. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS (2011). „DrugBank 3.0: a comprehensive resource for omics research on drugs”. Nucleic Acids Res. 39 (Database issue): D1035-41. DOI:10.1093/nar/gkq1126. PMC 3013709. PMID 21059682.  edit
  6. David S. Wishart, Craig Knox, An Chi Guo, Dean Cheng, Savita Shrivastava, Dan Tzur, Bijaya Gautam, and Murtaza Hassanali (2008). „DrugBank: a knowledgebase for drugs, drug actions and drug targets”. Nucleic Acids Res 36 (Database issue): D901-6. DOI:10.1093/nar/gkm958. PMC 2238889. PMID 18048412.  edit
  7. Ghose, A.K., Viswanadhan V.N., and Wendoloski, J.J. (1998). „Prediction of Hydrophobic (Lipophilic) Properties of Small Organic Molecules Using Fragment Methods: An Analysis of AlogP and CLogP Methods”. J. Phys. Chem. A 102: 3762-3772. DOI:10.1021/jp980230o. 
  8. Tetko IV, Tanchuk VY, Kasheva TN, Villa AE. (2001). „Estimation of Aqueous Solubility of Chemical Compounds Using E-State Indices”. Chem Inf. Comput. Sci. 41: 1488-1493. DOI:10.1021/ci000392t. PMID 11749573.  edit
  9. Ertl P., Rohde B., Selzer P. (2000). „Fast calculation of molecular polar surface area as a sum of fragment based contributions and its application to the prediction of drug transport properties”. J. Med. Chem. 43: 3714-3717. DOI:10.1021/jm000942e. PMID 11020286.  edit

Literatura

[uredi | uredi kod]

Spoljašnje veze

[uredi | uredi kod]